https://european-biotechnology.net/wp-content/uploads/2025/03/HDAC6-1030x643-1.jpg6431030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-25 07:45:082025-03-25 07:45:08Augustine Therapeutics NV raises €78m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_Insight_Czeslaw-Siekierski_tg-1030x435-1.jpeg4351030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-17 10:27:522025-03-17 10:27:52Poland breaks opposition to EU NGT deregulation
https://european-biotechnology.net/wp-content/uploads/2025/03/SpliceBio-1030x465-1.jpg4651030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-14 09:32:332025-03-14 09:32:33SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease
